204 results on '"Carver, Joseph R."'
Search Results
2. Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council Perspectives.
3. Contributors
4. Paraoxonase-1 Activity in Breast Cancer Patients Treated With Doxorubicin With or Without Trastuzumab
5. Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society
6. How to Diagnose and Manage Patients With Fluoropyrimidine-Induced Chest Pain: A Single Center Approach
7. Cardiology Involvement in Patients With Breast Cancer Treated With Trastuzumab
8. Cardiovascular Effects of CAR T Cell Therapy: A Retrospective Study
9. Treatment of corticosteroid refractory immune checkpoint inhibitor myocarditis with Infliximab: a case series
10. Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma
11. Cardiac Toxic Chemotherapy and Cancer Survivorship
12. Characterization of Pericarditis following Allogeneic Hematopoietic Cell Transplantation
13. Cardiac toxicity in the elderly and the role of cardio oncology
14. 24 - Cancer survivorship and comorbidity disease risk after cancer treatment
15. Abstract 20245: Fluoropyrimidine-Induced Cardiac Toxicity: Challenging the Current Paradigm
16. Cardio-oncology Fellowship Programs
17. CARDIOTOXICITY OF VENETOCLAX IN PATIENTS WITH ACUTE MYELOID LEUKEMIA: COMPARISON WITH ANTHRACYCLINES
18. Biomarker Approach to the Detection and Cardioprotective Strategies During Anthracycline Chemotherapy
19. Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients
20. Sustained Increases in IGFBP-7 May Be Related to Doxorubicin in Breast Cancer Patients
21. SUSTAINED INCREASES IN IGFBP7 FOLLOWING ANTHRACYCLINE TREATMENT IN BREAST CANCER PATIENTS
22. Tom Force (1951–2020)
23. Management of cardiac and pulmonary treatment–related side effects
24. Contributors
25. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors
26. Contributors
27. CARDIOLOGIST INVOLVEMENT IN BREAST CANCER PATIENTS TREATED WITH TRASTUZUMAB-BASED CANCER THERAPY REGIMEN
28. Comprehensive Assessment of Changes in Left Ventricular Diastolic Function With Contemporary Breast Cancer Therapy
29. Mechanisms and clinical course of cardiovascular toxicity of cancer treatment II. Hematology☆
30. Old and new directions of Cardio-Oncology
31. Helping the cardio-oncologist: from real life to guidelines
32. Cardiovascular Risk in Long-Term Survivors of Testicular Cancer
33. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of multiple myeloma: An evidence-based review
34. Effect of oral milrinone on mortality in severe chronic heart failure
35. Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma
36. Proteasome inhibitor associated cardiovascular adverse events: A real-world claims based study.
37. Detailed phenotyping reveals distinct trajectories of cardiovascular function and symptoms with exposure to modern breast cancer therapy
38. Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal
39. Chapter 23 - Cardio-oncology Fellowship Programs
40. Fluoropyrimidine-induced cardiac toxicity: challenging the current paradigm
41. Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer
42. Carfilzomib-associated cardiovascular adverse events: A systematic review and meta-analysis.
43. Persistence of ibrutinib-associated hypertension in CLL pts treated in a real-world experience.
44. Exercise intensity in cancer survivors: a matter of the heart
45. Council Clinical Perspective: Cardiovascular Health of Patients with Cancer and Cancer Survivors: A Roadmap to the Next Level
46. Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics–Related Cardiac Dysfunction
47. Prospective Study of Cardiac Events during Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma
48. Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab
49. Cardiovascular Health of Patients With Cancer and Cancer Survivors
50. 9 - Management of cardiac and pulmonary treatment–related side effects
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.